News summary

Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Source: GlobeNewswire - Biotech Financing • Published: 16 Nov 2026, 21:01

Summarized by Masters of Longevity from GlobeNewswire - Biotech Financing.

Windward closed an IPO and private placement raising about $251.2 million.

Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Key Takeaways
  • Windward raised $251.2 million from an IPO and placement.
  • Sanofi invested $50.0 million in a concurrent private placement.
  • Proceeds will fund development of WIN378 and WIN027.
Read the full article at GlobeNewswire - Biotech Financing ↗

Continue exploring

Recommended MoL Picks

MoL PickCan Exergaming Improve Balance? What Older Adults Should KnowMotion-controlled games may make balance practice easier to repeat. The evidence supports a structured adjunct—not a fall-proofing shortcut.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.